MGX
Metagenomi, Inc.
Biological Products, (No Diagnostic Substances)Nasdaq<br>Emerging growth company
Total Trades
17
Buys
1
Sells
13
Largest Trade
$1M+
Insiders
6
Institutional Funds
37
Inst. Value
$1M+
Activist Filings
2
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Thomas Brian C. | Director | SELL | $1K–$15K | 4K | $1.77 | Dec 8, 2025 |
| Wein Matthew | See Remarks | SELL | <$1K | 199 | $1.77 | Dec 8, 2025 |
| Wapnick Pamela | CFO | SELL | $1K–$15K | 2K | $1.77 | Dec 8, 2025 |
| Irish Jian | CEO | SELL | $1K–$15K | 2K | $1.77 | Dec 8, 2025 |
| Thomas Brian C. | Director | SELL | $1K–$15K | 3K | $1.81 | Dec 2, 2025 |
| Wapnick Pamela | CFO | GRANT | $100K–$500K | 120K | $1.60 | Dec 2, 2025 |
| Wapnick Pamela | CFO | SELL | $1K–$15K | 2K | $1.81 | Dec 2, 2025 |
| Irish Jian | CEO | SELL | $1K–$15K | 2K | $1.81 | Dec 2, 2025 |
| Irish Jian | CEO | GRANT | $100K–$500K | 249K | $1.60 | Dec 2, 2025 |
| Wein Matthew | See Remarks | SELL | <$1K | 199 | $1.81 | Dec 1, 2025 |
| Wein Matthew | See Remarks | GRANT | $100K–$500K | 96K | $1.60 | Dec 1, 2025 |
| Wein Matthew | See Remarks | SELL | <$1K | 199 | $1.75 | Jun 9, 2025 |
| Noonberg Sarah B. | Chief Medical Offi… | SELL | $1K–$15K | 5K | $1.75 | Jun 9, 2025 |
| Wapnick Pamela | CFO | SELL | $1K–$15K | 2K | $1.75 | Jun 9, 2025 |
| Thomas Brian C. | CEO | SELL | $15K–$50K | 11K | $1.75 | Jun 9, 2025 |
| Irish Jian | See Remarks | SELL | $1K–$15K | 6K | $1.75 | Jun 9, 2025 |
| Novo Holdings A/S | 10% Owner | BUY | $1M+ | 900K | $14.47 | Feb 16, 2024 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 37 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 1.1M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 628K | $1M+ | SH |
| Peapod Lane Capital LLC | 498K | $500K+ | SH |
| JANE STREET GROUP, LLC | 377K | $500K+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 254K | $100K–$500K | SH |
| PURA VIDA INVESTMENTS, LLC | 246K | $100K–$500K | SH |
| STATE STREET CORP | 120K | $100K–$500K | SH |
| WELLS FARGO & COMPANY/MN | 95K | $100K–$500K | SH |
| Resolute Advisors LLC | 90K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 65K | $100K–$500K | SH |
| Man Group plc | 56K | $50K–$100K | SH |
| MORGAN STANLEY | 54K | $50K–$100K | SH |
| BBR PARTNERS, LLC | 53K | $50K–$100K | SH |
| Fortitude Advisory Group L.L.C. | 39K | $50K–$100K | SH |
| PANAGORA ASSET MANAGEMENT INC | 33K | $50K–$100K | SH |
| Point72 Asset Management, L.P. | 27K | $15K–$50K | SH |
| Dynamic Technology Lab Private Ltd | 24K | $15K–$50K | SH |
| Vanguard Personalized Indexing Management, LLC | 16K | $15K–$50K | SH |
| UBS Group AG | 16K | $15K–$50K | SH |
| Peak Planning Group, LLC | 13K | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Nov 6, 2024
10.8%
4.1M shares
Sozo Ventures - TrueBridge Fund II, L.P.
SC 13G · May 10, 2024
1.6%
582K shares